| Target of rapamycin complex 2 subunit MAPKAP1 | TORC2 subunit MAPKAP1; Mitogen-activated protein kinase 2-associated protein 1; Stress-activated map kinase-interacting protein 1; SAPK-interacting protein 1; mSIN1 | Homo sapiens (human) |
| Serine/threonine-protein kinase Sgk1 | EC 2.7.11.1; Serum/glucocorticoid-regulated kinase 1 | Homo sapiens (human) |
| 3-phosphoinositide-dependent protein kinase 1 | hPDK1; EC 2.7.11.1 | Homo sapiens (human) |
| Cellular tumor antigen p53 | Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53 | Homo sapiens (human) |
| Cyclin-dependent kinase 1 | CDK1; EC 2.7.11.22; EC 2.7.11.23; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase | Homo sapiens (human) |
| Cyclin-dependent kinase 2 | EC 2.7.11.22; Cell division protein kinase 2; p33 protein kinase | Homo sapiens (human) |
| Protein Mdm4 | Double minute 4 protein; Mdm2-like p53-binding protein; Protein Mdmx; p53-binding protein Mdm4 | Homo sapiens (human) |
| Serine/threonine-protein kinase Chk2 | EC 2.7.11.1; CHK2 checkpoint homolog; Cds1 homolog; Hucds1; hCds1; Checkpoint kinase 2 | Homo sapiens (human) |
| Serine/threonine-protein kinase mTOR | EC 2.7.11.1; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic target of rapamycin; Rapamycin and FKBP12 target 1; Rapamycin target protein 1 | Homo sapiens (human) |
| E3 ubiquitin-protein ligase Mdm2 | EC 2.3.2.27; Double minute 2 protein; Hdm2; Oncoprotein Mdm2; RING-type E3 ubiquitin transferase Mdm2; p53-binding protein Mdm2 | Homo sapiens (human) |
| Cyclin-G1 | Cyclin-G | Homo sapiens (human) |
| Ubiquitin carboxyl-terminal hydrolase 2 | EC 3.4.19.12; 41 kDa ubiquitin-specific protease; Deubiquitinating enzyme 2; Ubiquitin thioesterase 2; Ubiquitin-specific-processing protease 2 | Homo sapiens (human) |
| Serine-protein kinase ATM | EC 2.7.11.1; Ataxia telangiectasia mutated; A-T mutated | Homo sapiens (human) |
| Rapamycin-insensitive companion of mTOR | AVO3 homolog; hAVO3 | Homo sapiens (human) |
| Ubiquitin carboxyl-terminal hydrolase 7 | EC 3.4.19.12; Deubiquitinating enzyme 7; Herpesvirus-associated ubiquitin-specific protease; Ubiquitin thioesterase 7; Ubiquitin-specific-processing protease 7 | Homo sapiens (human) |
| Target of rapamycin complex subunit LST8 | TORC subunit LST8; G protein beta subunit-like; Gable; Protein GbetaL; Mammalian lethal with SEC13 protein 8; mLST8 | Homo sapiens (human) |
| Tumor suppressor ARF | Alternative reading frame; ARF; Cyclin-dependent kinase inhibitor 2A; p14ARF | Homo sapiens (human) |
| Death domain-associated protein 6 | Daxx; hDaxx; ETS1-associated protein 1; EAP1; Fas death domain-associated protein | Homo sapiens (human) |
| PHD finger protein 20 | Glioma-expressed antigen 2; Hepatocellular carcinoma-associated antigen 58; Novel zinc finger protein; Transcription factor TZP | Homo sapiens (human) |
| Proline-rich protein 5 | Protein observed with Rictor-1; Protor-1 | Homo sapiens (human) |
| Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | PP2A B subunit isoform B'-gamma; PP2A B subunit isoform B56-gamma; PP2A B subunit isoform PR61-gamma; PP2A B subunit isoform R5-gamma; Renal carcinoma antigen NY-REN-29 | Homo sapiens (human) |